[HTML][HTML] Risk and protective factors for COVID-19 morbidity, severity, and mortality
J Zhang, X Dong, G Liu, Y Gao - Clinical reviews in allergy & immunology, 2023 - Springer
The outbreak of the coronavirus disease 2019 (COVID-19), caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global …
The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and …
M Greenhawt, EM Abrams, M Shaker, DK Chu… - The Journal of Allergy …, 2021 - Elsevier
Concerns for anaphylaxis may hamper severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) immunization efforts. We convened a multidisciplinary group of international …
(SARS-CoV-2) immunization efforts. We convened a multidisciplinary group of international …
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that have
mutations associated with increased transmission and antibody escape have arisen over the …
mutations associated with increased transmission and antibody escape have arisen over the …
[HTML][HTML] Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection
T cells are a critical component of the response to SARS-CoV-2, but their kinetics after
infection and vaccination are insufficiently understood. Using" spheromer" peptide-MHC …
infection and vaccination are insufficiently understood. Using" spheromer" peptide-MHC …
[HTML][HTML] COVID-19 vaccines: a review of the safety and efficacy of current clinical trials
Various strategies have been designed to contain the COVID-19 pandemic. Among them,
vaccine development is high on the agenda in spite of the unknown duration of the …
vaccine development is high on the agenda in spite of the unknown duration of the …
[HTML][HTML] COVID-19 pandemic and vaccines update on challenges and resolutions
The coronavirus disease (COVID-19) is caused by a positive-stranded RNA virus called
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), belonging to the …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), belonging to the …
[HTML][HTML] Cutaneous adverse reactions associated with SARS-CoV-2 vaccines
Many patients are receiving SARS-CoV-2 vaccinations, which have been associated with a
variety of adverse effects. Cutaneous adverse reactions to SARS-CoV-2 vaccinations have …
variety of adverse effects. Cutaneous adverse reactions to SARS-CoV-2 vaccinations have …
[HTML][HTML] A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges
The present SARS-CoV-2 induced COVID-19 pandemic is responsible for millions of deaths,
illnesses, and economic loss worldwide. There are 21 COVID-19 vaccines from different …
illnesses, and economic loss worldwide. There are 21 COVID-19 vaccines from different …
E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy …
WB Wang, Y Liang, YQ Jin, J Zhang, JG Su… - Journal of Molecular …, 2021 - Elsevier
The pandemic of the COVID-19 disease caused by SARS-CoV-2 has led to more than 200
million infections and over 4 million deaths worldwide. The progress in the developments of …
million infections and over 4 million deaths worldwide. The progress in the developments of …
[HTML][HTML] COVID-19: Insights into potential vaccines
People around the world ushered in the new year 2021 with a fear of COVID-19, as family
members have lost their loved ones to the disease. Millions of people have been infected …
members have lost their loved ones to the disease. Millions of people have been infected …